AI-generated draft from CMS source. Review and verify clinical accuracy before use.
1. MEDICAL NECESSITY PATHWAY
Facet joint destruction by neurolytic agent (CPT 64635) requires documentation of chronic, moderate-to-severe axial lumbar or sacral pain lasting at least 3 months, functional impairment, failure of conservative management, and appropriate diagnostic confirmation through facet joint procedures. Medical record must exclude alternative non-facet diagnoses, document absence of untreated radiculopathy or neurogenic claudication (except radiculopathy from facet synovial cyst), and demonstrate patient is not a candidate for radiofrequency ablation (RFA) or has failed prior diagnostic medial branch blocks (MBB). Pain and disability scales must be documented at baseline and after diagnostic procedures. Image guidance with fluoroscopy or CT is required.
2. CONSERVATIVE CARE / PRIOR TREATMENT SUPPORT
– The patient must have failed a minimum of 3 months of non-invasive conservative management.
– Not clearly stated in source specific types of conservative care other than non-invasive management failures.
– Common documentation support:
Patient has participated in conservative treatment including activity modification, home exercise program, medication management, and/or physical therapy without adequate sustained functional improvement.
3. DIAGNOSIS / SYMPTOM SUPPORT
– Documentation of chronic, moderate-to-severe lumbar or sacral axial pain present for at least 3 months causing functional deficit documented by pain and disability assessment tools.
– Documentation excluding untreated radiculopathy or neurogenic claudication unless related to facet synovial cyst.
– Copy-ready example:
Patient reports chronic low back or sacral pain consistent with the documented diagnosis and corresponding facet joint pain generator. Symptoms have persisted despite conservative care and continue to limit function as measured by standardized pain and disability scales.
4. OBJECTIVE / IMAGING / EXAM CORRELATION
– Imaging (MRI, CT) or other diagnostic studies must exclude non-facet pathology such as fracture, tumor, infection, or significant deformity.
– Diagnostic facet joint procedures such as medial branch blocks are required to confirm pain relief of at least 80% to support facet joint as pain generator.
– Copy-ready example:
Clinical findings and available diagnostic imaging studies support the requested facet joint denervation as medically reasonable and necessary for the documented lumbar or sacral facet pain generator.
5. PROCEDURE-SPECIFIC REQUIREMENTS
– Prior to thermal neurolytic destruction (CPT 64635), patient must have had at least 2 medically reasonable and necessary diagnostic medial branch blocks each providing ≥80% pain relief consistent with agent duration.
– Documentation must explain why patient is not a candidate for RFA (e.g., spinal pseudarthrosis, implanted electrical device).
– Image guidance with fluoroscopy or CT is mandatory; ultrasound or MRI guidance and procedures without image guidance are non-covered.
– Only one facet joint per code; 64635 reports single lumbar or sacral joint; additional levels reported with 64636.
– Laterality documented; bilateral procedures require modifier -50 on each line.
– Frequency limits: maximum 2 denervation sessions per spinal region in rolling 12 months.
– Procedures after anterior lumbar interbody fusion (ALIF) are non-covered.
– Non-thermal denervation modalities or injections with non-FDA approved substances (e.g., biologics) are non-covered.
– Moderate or deep sedation, general anesthesia, and MAC are not reasonable during facet injections; moderate sedation for RFA or cyst rupture only with documented medical necessity.
– Do not report diagnostic injections at the same level as previous successful RFA.
– One to two levels allowed per session; three or four level procedures are non-covered.
– CPT coding notes: report facet joints injected, not number of nerves; bilateral injections reported as one unit with modifier -50.
– KX modifier required for diagnostic injections; avoid aberrant use to prevent focused review.
6. READY-TO-PASTE AUTHORIZATION PARAGRAPH
Patient has diagnosis-supported chronic lumbar or sacral facet joint pain consistent with CPT 64635 for neurolytic destruction by thermal agent. Symptoms cause functional limitation and have persisted for at least 3 months despite appropriate conservative care. Clinical assessment, diagnostic medial branch block results showing ≥80% pain relief on two separate occasions, and imaging studies excluding non-facet pathology support medical necessity. The patient is not a candidate for radiofrequency ablation as documented. The procedure will be performed using fluoroscopic or CT guidance with appropriate coding and frequency limits per CMS LCD L38765 and article A58350.
7. READY-TO-PASTE CHART NOTE LANGUAGE
Medical necessity reviewed. Patient has persistent moderate-to-severe lumbar/sacral axial pain consistent with facet joint syndrome, confirmed by two diagnostic medial branch blocks showing ≥80% pain relief. Conservative care has been inadequate. Imaging excludes alternative diagnoses. Patient is not a candidate for RFA. Based on clinical exam, history, and diagnostic results, proceeding with neurolytic facet nerve destruction (CPT 64635) is medically reasonable and necessary.
8. APPEAL / DENIAL SUPPORT LANGUAGE
The requested CPT 64635 procedure is supported by documented chronic lumbar/sacral facet joint pain causing functional impairment despite failure of conservative measures. Two diagnostic medial branch blocks verified the facet joint pain source with sustained ≥80% pain relief. Imaging and clinical evaluation exclude alternative causes. The patient is appropriately documented as not a candidate for radiofrequency ablation. Based on CMS LCD L38765 and article A58350 criteria, this procedure meets medical necessity and denial should be reconsidered in light of submitted records and policy requirements.
9. RECORDS / ROI TO REQUEST
– Physical therapy notes and progress documentation
– Home exercise program compliance notes
– Medication trial logs and pain medication history
– Imaging reports (MRI, CT) of lumbar/sacral spine
– Records of prior diagnostic medial branch blocks with documented pain relief percentage and duration
– Pain and disability scale assessments (e.g., NRS, VAS, Oswestry Disability Index) at baseline and after injections
– Procedure and operative reports if applicable
– Referring provider assessment and documentation supporting diagnosis
10. CAUTIONS / NOT COVERED
– Facet joint interventions without fluoroscopic or CT guidance are non-covered (including ultrasound or MRI guidance).
– Use of non-thermal denervation methods (chemical neurolysis, low-grade thermal energy <80°C, laser neurolysis, cryoablation) non-covered.
– Injections with non-FDA designated substances such as biologics are non-covered.
– Procedures performed within three or four levels during one session are non-covered.
– Facet joint procedures after anterior lumbar interbody fusion (ALIF) are not covered.
– Moderate or deep sedation, general anesthesia, and MAC are generally not reasonable for injections; moderate sedation for RFA or cyst rupture requires medical necessity documentation.
– Diagnostic injections at the same level as previously successful RFA are not reasonable and necessary.
– Procedures for generalized pain syndromes like fibromyalgia or chronic centralized pain syndromes are non-covered.
– Not clearly stated in source for specifics beyond these limitations.
This CMS Medicare article (A58350, version 22) provides billing and coding guidance for facet joint interventions for pain management, complementing the related LCD L38765 (version 27) from the contractor/MAC. The focus is on procedures performed for chronic axial neck or low back pain diagnosed as facet joint-mediated pain, including diagnostic and therapeutic intra-articular injections, medial branch blocks (MBB), radiofrequency ablation (RFA), and facet cyst rupture/aspiration.
Coverage applies to cervical/thoracic and lumbar/sacral facet joint interventions with CPT/HCPCS codes primarily in the 64490–64495 series for injections and 64633–64636 for neurolytic (thermal) nerve destruction, notably including code 64635 for lumbar/sacral facet joint denervation. Only procedures performed with fluoroscopic or CT guidance are covered; ultrasound guidance and procedures without imaging are not covered. Non-thermal denervation modalities, intra-facet implants, and injections with biological agents not FDA-approved for this use are also non-covered.
Covered ICD-10 diagnoses generally include various forms of spondylosis, ankylosing hyperostosis [Forestier], and other specified dorsopathies of cervical, thoracic, lumbar, cervicothoracic, thoracolumbar, and lumbosacral regions (e.g., M47.812–M47.817, M48.12–M48.17, M53.82–M53.87).
Clinical criteria for coverage require:
– Moderate-to-severe chronic axial neck or low back pain lasting at least 3 months with functional impairment documented via a pain or disability scale,
– Failure of non-invasive conservative management,
– Absence of untreated radiculopathy or neurogenic claudication except when caused by facet cyst,
– No other clinical or radiologic pathology explaining the pain.
Diagnostic facet joint injections or MBBs require documentation of at least 80% pain relief from the initial procedure to justify a second confirmatory diagnostic injection. Therapeutic injections require prior diagnostic confirmation and evidence of consistent at least 50% pain relief or functional improvement. RFA is covered after diagnostic confirmation with sustained 80% pain relief and repeated as clinically justified with at least 50% pain reduction or functional improvement lasting six months or more.
Facet cyst aspiration is medically necessary only when advanced imaging confirms nerve root compression by the cyst, and clinical symptoms are documented. Repeat aspiration is limited to once per cyst with documented improvement.
Limitations include:
– Facet interventions without CT or fluoroscopic guidance are non-covered, including ultrasound guidance;
– Use of moderate or deep sedation, general anesthesia, or monitored anesthesia care (MAC) is not reasonable for injections but may be considered for RFA or cyst rupture if medically necessary and documented;
– Only one spinal region treated per session;
– A maximum of 4 diagnostic or therapeutic sessions per spinal region annually;
– One to two levels (unilateral or bilateral) per session are allowed; three or more levels are non-covered;
– Diagnostic injections or MBB at the same level as a prior successful RFA are non-covered;
– Procedures for generalized pain syndromes such as fibromyalgia are not reasonable and necessary.
Providers must document pain and disability assessments using consistent validated scales at baseline and after procedures, including scales such as the Numerical Rating Scale (NRS), Visual Analog Scale (VAS), Oswestry Disability Index (ODI), and others.
Claims must include valid ICD-10 codes accurately describing the patient’s condition, NPI of referring/ordering physicians when required, and adhere to NCCI and OPPS edits. The KX modifier is required for diagnostic injections, with inappropriate use possibly triggering audits.
Providers performing these procedures must be appropriately trained and credentialed, with competence in relevant anatomy, pharmacology, procedure technique, and imaging interpretation as per Medicare Program Integrity Manual requirements.
In summary, this article and related LCD guide Medicare coverage decisions for image-guided facet joint injections and neurolytic denervation for chronic axial spine pain after failed conservative management, following strict clinical criteria, documentation, frequency limits, and procedure coding guidelines.
Not clearly stated in source: specific documentation format for medical necessity beyond standard medical record requirements.
Source URL: https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=58350&ver=22